Literature DB >> 26041910

Astrocytes Are Primed by Chronic Neurodegeneration to Produce Exaggerated Chemokine and Cell Infiltration Responses to Acute Stimulation with the Cytokines IL-1β and TNF-α.

Edel Hennessy1, Éadaoin W Griffin1, Colm Cunningham2.   

Abstract

Microgliosis and astrogliosis are standard pathological features of neurodegenerative disease. Microglia are primed by chronic neurodegeneration such that toll-like receptor agonists, such as LPS, drive exaggerated cytokine responses on this background. However, sterile inflammatory insults are more common than direct CNS infection in the degenerating brain and these insults drive robust IL-1β and TNF-α responses. It is unclear whether these pro-inflammatory cytokines can directly induce exaggerated responses in the degenerating brain. We hypothesized that glial cells in the hippocampus of animals with chronic neurodegenerative disease (ME7 prion disease) would display exaggerated responses to central cytokine challenges. TNF-α or IL-1β were administered intrahippocampally to ME7-inoculated mice and normal brain homogenate-injected (NBH) controls. Both IL-1β and TNF-α produced much more robust IL-1β synthesis in ME7 than in NBH animals and this occurred exclusively in microglia. However, there was strong nuclear localization of the NFκB subunit p65 in the astrocyte population, associated with marked astrocytic synthesis of the chemokines CXCL1 and CCL2 in response to both cytokine challenges in ME7 animals. Conversely, very limited expression of these chemokines was apparent in NBH animals similarly challenged. Thus, astrocytes are primed in the degenerating brain to produce exaggerated chemokine responses to acute stimulation with pro-inflammatory cytokines. Furthermore, this results in markedly increased neutrophil, T-cell, and monocyte infiltration in the diseased brain. These data have significant implications for acute sterile inflammatory insults such as stroke and traumatic brain injury occurring on a background of aging or neurodegeneration.
Copyright © 2015 Hennessy et al.

Entities:  

Keywords:  astrocyte; chemokine; cytokine; microglia; neurodegeneration; neuroinflammation

Mesh:

Substances:

Year:  2015        PMID: 26041910      PMCID: PMC4452550          DOI: 10.1523/JNEUROSCI.2745-14.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  41 in total

1.  Differential induction of interleukin-1beta and tumour necrosis factor-alpha may account for specific patterns of leukocyte recruitment in the brain.

Authors:  Donatienne Blond; Sandra J Campbell; Angus G Butchart; V Hugh Perry; Daniel C Anthony
Journal:  Brain Res       Date:  2002-12-20       Impact factor: 3.252

2.  Genomic analysis of reactive astrogliosis.

Authors:  Jennifer L Zamanian; Lijun Xu; Lynette C Foo; Navid Nouri; Lu Zhou; Rona G Giffard; Ben A Barres
Journal:  J Neurosci       Date:  2012-05-02       Impact factor: 6.167

3.  Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta.

Authors:  I Y Chung; E N Benveniste
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

4.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis.

Authors:  Simon Yona; Ki-Wook Kim; Yochai Wolf; Alexander Mildner; Diana Varol; Michal Breker; Dalit Strauss-Ayali; Sergey Viukov; Martin Guilliams; Alexander Misharin; David A Hume; Harris Perlman; Bernard Malissen; Elazar Zelzer; Steffen Jung
Journal:  Immunity       Date:  2012-12-27       Impact factor: 31.745

5.  Exaggerated neutrophil-mediated reperfusion injury after ischemic stroke in a rodent model of type 2 diabetes.

Authors:  Leslie Ritter; Lisa Davidson; Melissa Henry; Grace Davis-Gorman; Helena Morrison; Jennifer B Frye; Zoe Cohen; Sierra Chandler; Paul McDonagh; Janet L Funk
Journal:  Microcirculation       Date:  2011-10       Impact factor: 2.628

6.  Targeting of Gr-1+,CCR2+ monocytes in collagen-induced arthritis.

Authors:  Hilke Brühl; Josef Cihak; Jirí Plachý; Leoni Kunz-Schughart; Marianne Niedermeier; Andrea Denzel; Manuel Rodriguez Gomez; Yvonne Talke; Bruno Luckow; Manfred Stangassinger; Matthias Mack
Journal:  Arthritis Rheum       Date:  2007-09

7.  Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes [corrected].

Authors:  Wendy L Thompson; Linda J Van Eldik
Journal:  Brain Res       Date:  2009-07-03       Impact factor: 3.252

8.  Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing.

Authors:  J L Pace; S W Russell; B A Torres; H M Johnson; P W Gray
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

9.  Interleukin-1 exerts distinct actions on different cell types of the brain in vitro.

Authors:  Ying An; Qun Chen; Ning Quan
Journal:  J Inflamm Res       Date:  2011-01

10.  Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium.

Authors:  Carol Murray; David J Sanderson; Chris Barkus; Robert M J Deacon; J Nicholas P Rawlins; David M Bannerman; Colm Cunningham
Journal:  Neurobiol Aging       Date:  2010-05-14       Impact factor: 4.673

View more
  60 in total

Review 1.  Modulators of microglial activation and polarization after intracerebral haemorrhage.

Authors:  Xi Lan; Xiaoning Han; Qian Li; Qing-Wu Yang; Jian Wang
Journal:  Nat Rev Neurol       Date:  2017-05-19       Impact factor: 42.937

2.  Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  T N C Magalhães; M Weiler; C V L Teixeira; T Hayata; A S Moraes; V O Boldrini; L M Dos Santos; B M de Campos; T J R de Rezende; H P G Joaquim; L L Talib; O V Forlenza; F Cendes; Marcio L F Balthazar
Journal:  Mol Neurobiol       Date:  2017-10-16       Impact factor: 5.590

Review 3.  The role of inflammation in depression: from evolutionary imperative to modern treatment target.

Authors:  Andrew H Miller; Charles L Raison
Journal:  Nat Rev Immunol       Date:  2016-01       Impact factor: 53.106

4.  Alcohol exposure-induced neurovascular inflammatory priming impacts ischemic stroke and is linked with brain perivascular macrophages.

Authors:  Antoine Drieu; Anastasia Lanquetin; Damien Levard; Martina Glavan; Francisco Campos; Aurélien Quenault; Eloïse Lemarchand; Mikaël Naveau; Anne Lise Pitel; José Castillo; Denis Vivien; Marina Rubio
Journal:  JCI Insight       Date:  2020-02-27

5.  Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels.

Authors:  Yeri Kim; Jarred M Griffin; Mohd N Mat Nor; Jie Zhang; Peter S Freestone; Helen V Danesh-Meyer; Ilva D Rupenthal; Monica Acosta; Louise F B Nicholson; Simon J O'Carroll; Colin R Green
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 6.  Astrocytes: Heterogeneous and Dynamic Phenotypes in Neurodegeneration and Innate Immunity.

Authors:  Colm Cunningham; Aisling Dunne; Ana Belen Lopez-Rodriguez
Journal:  Neuroscientist       Date:  2018-11-17       Impact factor: 7.519

7.  Modulation of Behavioral Deficits and Neurodegeneration by Tannic Acid in Experimental Stroke Challenged Wistar Rats.

Authors:  Mohammad Ashafaq; Heena Tabassum; Suhel Parvez
Journal:  Mol Neurobiol       Date:  2016-09-27       Impact factor: 5.590

8.  Repetitive Closed-Head Impact Model of Engineered Rotational Acceleration Induces Long-Term Cognitive Impairments with Persistent Astrogliosis and Microgliosis in Mice.

Authors:  Huazhen Chen; Abhishek Desai; Hee-Yong Kim
Journal:  J Neurotrauma       Date:  2017-04-26       Impact factor: 5.269

Review 9.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-06-01

Review 10.  An Integrative Overview of Non-Amyloid and Non-Tau Pathologies in Alzheimer's Disease.

Authors:  Blaise W Menta; Russell H Swerdlow
Journal:  Neurochem Res       Date:  2018-08-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.